It seems like..
That it’s not only THTX who believes two long acting drugs regime is the path forward…
“However, despite findings of efficacy in studies when given daily, weekly, or as an injection up to every 6 months, lenacapavir is dependent on antiretroviral drugs that must be given daily.
These are undoubtedly promising results; however, lenacapavir needs a long-acting partner if it is to deliver on its promise of being part of a comprehensive long-acting regimen,” noted Chloe Orkin, MBBCH, of the University Queen Mary in London, writing in a commentary accompanying the study. "With the development of islatravir slowed by unexpected immunological findings, the identity of this partner is far from clear."
https://lesactualites.news/sante/medicament-anti-vih-a-action-prolongee-prometteur-pour-les-patients-naifs-de-traitement/